Herman Groepenhoff1, Marieke J Overbeek1, Massimiliano Mulè2, Mart van der Plas3, Paola Argiento4, Francisco C Villafuerte5, Sophia Beloka6, Vitalie Faoro6, Jose L Macarlupu5, Herve Guenard7, Claire de Bisschop8, Jean-Benoit Martinot9, Rebecca Vanderpool6, Dante Penaloza5, Robert Naeije10. 1. Department of Pulmonology, VU University Medical Center, Amsterdam, The Netherlands. 2. Department of Cardiology, University of Catania, Catania, Italy. 3. Department of Respiratory Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. 4. Department of Cardiology, Monaldi Hospital, Second University of Naples, Naples, Italy. 5. Department of Medicine and High Altitude Research Institute, Universidad Peruana Cayetano Heredia, Lima, Peru. 6. Department of Pathophysiology, Faculty of Medicine, Free University of Brussels, Brussels, Belgium. 7. Department of Physiology, University Hospital Bordeaux, Bordeaux, France. 8. Laboratory of Physiologic Adaptations to Physical Activities, Poitiers University, Poitiers, France. 9. Department of Pneumology, St Elisabeth Hospital, Namur, Belgium. 10. Department of Pathophysiology, Faculty of Medicine, Free University of Brussels, Brussels, Belgium. Electronic address: rnaeije@ulb.ac.be.
Abstract
BACKGROUND: Chronic mountain sickness (CMS) is characterized by a combination of excessive erythrocytosis,severe hypoxemia, and pulmonary hypertension, all of which affect exercise capacity. METHODS: Thirteen patients with CMS and 15 healthy highlander and 15 newcomer lowlander control subjects were investigated at an altitude of 4,350 m (Cerro de Pasco, Peru). All of them underwent measurements of diffusing capacity of lung for nitric oxide and carbon monoxide at rest, echocardiography for estimation of mean pulmonary arterial pressure and cardiac output at rest and at exercise, and an incremental cycle ergometer cardiopulmonary exercise test. RESULTS: The patients with CMS, the healthy highlanders, and the newcomer lowlanders reached a similar maximal oxygen uptake at 32 1, 32 2, and 33 2 mL/min/kg, respectively, mean SE( P 5 .8), with ventilatory equivalents for C O 2 vs end-tidal P CO 2 , measured at the anaerobic threshold,of 0.9 0.1, 1.2 0.1, and 1.4 0.1 mm Hg, respectively ( P , .001); arterial oxygen content of 26 1, 21 2, and 16 1 mL/dL, respectively ( P , .001); diffusing capacity for carbon monoxide corrected for alveolar volume of 155% 4%, 150% 5%, and 120% 3% predicted, respectively( P , .001), with diffusing capacity for nitric oxide and carbon monoxide ratios of 4.7 0.1 at sea level decreased to 3.6 0.1, 3.7 0.1, and 3.9 0.1, respectively ( P , .05) and a maximal exercise mean pulmonary arterial pressure at 56 4, 42 3, and 31 2 mm Hg, respectively ( P , .001). CONCLUSIONS: The aerobic exercise capacity of patients with CMS is preserved in spite of severe pulmonary hypertension and relative hypoventilation, probably by a combination of increased oxygen carrying capacity of the blood and lung diffusion, the latter being predominantly due to an increased capillary blood volume.
BACKGROUND: Chronic mountain sickness (CMS) is characterized by a combination of excessive erythrocytosis,severe hypoxemia, and pulmonary hypertension, all of which affect exercise capacity. METHODS: Thirteen patients with CMS and 15 healthy highlander and 15 newcomer lowlander control subjects were investigated at an altitude of 4,350 m (Cerro de Pasco, Peru). All of them underwent measurements of diffusing capacity of lung for nitric oxide and carbon monoxide at rest, echocardiography for estimation of mean pulmonary arterial pressure and cardiac output at rest and at exercise, and an incremental cycle ergometer cardiopulmonary exercise test. RESULTS: The patients with CMS, the healthy highlanders, and the newcomer lowlanders reached a similar maximal oxygen uptake at 32 1, 32 2, and 33 2 mL/min/kg, respectively, mean SE( P 5 .8), with ventilatory equivalents for C O 2 vs end-tidal P CO 2 , measured at the anaerobic threshold,of 0.9 0.1, 1.2 0.1, and 1.4 0.1 mm Hg, respectively ( P , .001); arterial oxygen content of 26 1, 21 2, and 16 1 mL/dL, respectively ( P , .001); diffusing capacity for carbon monoxide corrected for alveolar volume of 155% 4%, 150% 5%, and 120% 3% predicted, respectively( P , .001), with diffusing capacity for nitric oxide and carbon monoxide ratios of 4.7 0.1 at sea level decreased to 3.6 0.1, 3.7 0.1, and 3.9 0.1, respectively ( P , .05) and a maximal exercise mean pulmonary arterial pressure at 56 4, 42 3, and 31 2 mm Hg, respectively ( P , .001). CONCLUSIONS: The aerobic exercise capacity of patients with CMS is preserved in spite of severe pulmonary hypertension and relative hypoventilation, probably by a combination of increased oxygen carrying capacity of the blood and lung diffusion, the latter being predominantly due to an increased capillary blood volume.
Authors: Chantal Dedobbeleer; Alia Hadefi; Aurelien Pichon; Francisco Villafuerte; Robert Naeije; Philippe Unger Journal: Int J Cardiovasc Imaging Date: 2015-02-10 Impact factor: 2.357
Authors: Melisa Kiyamu; Fabiola León-Velarde; María Rivera-Chira; Gianpietro Elías; Tom D Brutsaert Journal: High Alt Med Biol Date: 2015-05-15 Impact factor: 1.981
Authors: Robert Naeije; Rebecca Vanderpool; Bishnu P Dhakal; Rajeev Saggar; Rajan Saggar; Jean-Luc Vachiery; Gregory D Lewis Journal: Am J Respir Crit Care Med Date: 2013-01-24 Impact factor: 21.405
Authors: Glen E Foster; Philip N Ainslie; Mike Stembridge; Trevor A Day; Akke Bakker; Samuel J E Lucas; Nia C S Lewis; David B MacLeod; Andrew T Lovering Journal: J Physiol Date: 2014-01-06 Impact factor: 5.182
Authors: José Luis Macarlupú; Gustavo Vizcardo-Galindo; Rómulo Figueroa-Mujíca; Nicolas Voituron; Jean-Paul Richalet; Francisco C Villafuerte Journal: Exp Physiol Date: 2021-09-30 Impact factor: 2.858
Authors: Kaetan J Vyas; David Danz; Robert H Gilman; Robert A Wise; Fabiola León-Velarde; J Jaime Miranda; William Checkley Journal: High Alt Med Biol Date: 2015-05-14 Impact factor: 1.981
Authors: Alexander B Hansen; Sachin B Amin; Florian Hofstätter; Hendrik Mugele; Lydia L Simpson; Christopher Gasho; Tony G Dawkins; Michael M Tymko; Philip N Ainslie; Francisco C Villafuerte; Christopher M Hearon; Justin S Lawley; Gilbert Moralez Journal: Am J Physiol Heart Circ Physiol Date: 2022-03-25 Impact factor: 5.125